<DOC>
	<DOCNO>NCT00314665</DOCNO>
	<brief_summary>This research study patient diagnose chronic uveitis , disease cause inflammation eye . Patients currently treat Remicade , Humira , Methotrexate similar chemotherapy type drug control inflammation . Despite medication , patient still inflammation eye . Patients ask add additional drug , thalidomide .</brief_summary>
	<brief_title>Use Thalidomide Chronic Uveitis</brief_title>
	<detailed_description>Patients study approximately 24 week . The visit screening , baseline ( week 0 ) , week 4,8,12 , 24 . The purpose research study see Thalidomide safe effective treatment patient chronic inflammation eye . Thalidomide approve Food Drug Administration ( FDA ) leprosy skin condition , erythema nodosum leprosum ( ENL ) . The drug work many different way , include anti-inflammation drug . Therefore , think drug might able improve symptom lung function . At time , drug approve use uveitis .</detailed_description>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>You ask take part research study diagnose chronic uveitis , disease cause inflammation eye . You currently treat Remicade , Humira , Methotrexate similar chemotherapy type drug control inflammation . Despite medication , still inflammation eye . You ask add additional drug , thalidomide . You participate research study follow apply : Pregnant If man woman willing take adequate birth control measure comply FDAmandated S.T.E.P.S.Ã¢ program . . If breast feeding woman If significant peripheral neuropathy ( numbness tingle hand foot ) Have recent blood clot leg lung If currently receive biphosphonates zoledronic acid ( fosamax )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Sarcoidosis</keyword>
	<keyword>Chronic Uveitis</keyword>
	<keyword>Uveitis</keyword>
	<keyword>Thalidomide</keyword>
</DOC>